Miltenyi Biotec (Germany)
In research, Miltenyi Biotec (Germany) stands highest in Life Sciences (#3,754 of 14,347 worldwide), Medicine (#12,823 of 17,978 worldwide) and Health Sciences (#15,911 of 20,462 worldwide), over all time. Relative to its size it is most specialised in Oncology, Molecular Biology and Biochemistry, Genetics and Molecular Biology — Oncology is 21.5× its share of world research.
- World rank, 2022–2025
- #10,650 of 28,054 · #9,344 all time
- Rank in Germany
- #429 of 1,178
- Research works
- 441 ▲ 20% vs 2013–17
- Citations
- 13k 29.7 per fractional work
- Top-10% rate
- 11.0% record average 16.5%
- Open access
- 40% world 28%
What is Miltenyi Biotec (Germany) known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| Life SciencesDomain | #3,754 of 14,347 | 16.8% | 237 | |
| MedicineField | #12,823 of 17,978 | 15.6% | 146 | |
| Health SciencesDomain | #15,911 of 20,462 | 15.5% | 148 | |
| Biochemistry, Genetics and Molecular BiologyField | #6,566 of 7,814 | 15.6% | 135 |
Each strip is that field’s whole ranked pool, with the notch where Miltenyi Biotec (Germany) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Miltenyi Biotec (Germany) specialise in?
Where its research is concentrated relative to its size: Oncology takes 21.5× the share of its output that it takes of world research.
- OncologySubfield · 22.9 works22×
- Molecular BiologySubfield · 20.7 works7.3×
- Biochemistry, Genetics and Molecular BiologyField · 28.4 works5.7×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 15.1×. Every wedge is a field page.
- Immunology and Microbiology 15.1×
- Biochemistry, Genetics and Molecular Biology 5.7×
- Medicine 2.1×
- Chemical Engineering 0.8×
- Veterinary 0.7×
- Pharmacology, Toxicology and Pharmaceutics 0.6×
- Engineering 0.5×
- Economics, Econometrics and Finance 0.5×
- Materials Science 0.3×
- Neuroscience 0.3×
- Chemistry 0.2×
- Health Professions 0.2×
- Physics and Astronomy 0.1×
- Mathematics 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Environmental Science 0.1×
- Earth and Planetary Sciences 0.0×
- Social Sciences 0.0×
Who are the top researchers at Miltenyi Biotec (Germany)?
Ranked on the composite score, Ian Johnston, Andrew Kaiser and H Bohnenkamp lead among researchers whose main affiliation is Miltenyi Biotec (Germany).
- 1 Ian Johnston Germany · #367,177 worldwide 60 citations · 23 works
- 2 Andrew Kaiser Germany · #676,925 worldwide 58 citations · 15 works
- 3 H Bohnenkamp Germany · #721,731 worldwide 22 citations · 15 works
- 4 Mario Assenmacher Germany · #1,422,016 worldwide 21 citations · 22 works
- 5 Andreas Bosio Germany · #1,450,446 worldwide 18 citations · 23 works
Which keywords describe research at Miltenyi Biotec (Germany)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunotherapy, Lymphoma, Tumor Regression, Leukemia, CAR T Cells, Chimeric Antigen Receptor and Gene Expression.
- Vaccine Adjuvants
- Dendritic Cells
- AAV
- Foxp3
- Biosimilars
- Recombinant Protein
- Antigen Presentation
- Fc Receptors
- Antibody Engineering
- Biopharmaceuticals
- Gene Therapy
- Regenerative Medicine
- Immunity
- NK Cell Recognition
- Single-Cell
- Monoclonal Antibodies
- Gene Expression
- CAR T Cells
- Tumor Regression
- Immunotherapy
- Cancer Immunotherapy
- Lymphoma
- Leukemia
- Chimeric Antigen Receptor
- Glycosylation
- RNA-Seq
- Transcriptomics
- Natural Killer Cells
- Cell Culture
- Cancer
- Autoimmunity
- Therapeutic Antibodies
- Biosensors
- Immunogenicity
- Mammalian Cells
- Bioanalytical Methods
- Innate Immunity
- TGF-ß
- Viral Vectors
- Tumor Antigen
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer Immunotherapy22▲ 150×3 topics
- Immunotherapy22▲ 32×11 topics
- Lymphoma21▲ 137×3 topics
- Tumor Regression20▲ 197×2 topics
- Leukemia20▲ 251×2 topics
- CAR T Cells20▲ 282×1 topic
- Chimeric Antigen Receptor20▲ 282×1 topic
- Gene Expression8▲ 13×5 topics
- Glycosylation6▲ 55×3 topics
- Monoclonal Antibodies6▲ 67×3 topics
- RNA-Seq6▲ 54×2 topics
- Single-Cell5▲ 128×1 topic
- Transcriptomics5▲ 128×1 topic
- NK Cell Recognition5▲ 76×1 topic
- Natural Killer Cells5▲ 76×1 topic
- Immunity4▲ 12×6 topics
- Cell Culture4▲ 36×2 topics
- Regenerative Medicine4▲ 16×4 topics
- Cancer4▲ 2.9×11 topics
- Gene Therapy4▲ 20×4 topics
- Autoimmunity3▲ 22×3 topics
- Biopharmaceuticals3▲ 61×3 topics
- Therapeutic Antibodies3▲ 46×2 topics
- Antibody Engineering3▲ 55×1 topic
- Biosensors3▲ 5.9×7 topics
- Fc Receptors3▲ 55×1 topic
- Immunogenicity3▲ 69×2 topics
- Antigen Presentation3▲ 32×2 topics
- Mammalian Cells3▲ 119×1 topic
- Recombinant Protein3▲ 119×1 topic
- Bioanalytical Methods3▲ 140×1 topic
- Biosimilars3▲ 140×1 topic
- Innate Immunity3▲ 8.7×5 topics
- Foxp32▲ 76×1 topic
- TGF-ß2▲ 17×1 topic
- AAV2▲ 61×1 topic
- Viral Vectors2▲ 61×1 topic
- Dendritic Cells2▲ 23×2 topics
- Tumor Antigen2▲ 34×1 topic
- Vaccine Adjuvants2▲ 34×1 topic
Which research topics does Miltenyi Biotec (Germany) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Single-cell and spatial transcriptomics, Immune Cell Function and Interaction and Monoclonal and Polyclonal Antibodies Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 20 works
- 2 Single-cell and spatial transcriptomics Molecular Biology 5 works
- 3 Immune Cell Function and Interaction Immunology 5 works
- 4 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
- 5 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 3 works
- 6 Biosimilars and Bioanalytical Methods Immunology 3 works
- 7 T-cell and B-cell Immunology Immunology 2 works
- 8 Virus-based gene therapy research Genetics 2 works
- 9 Immunotherapy and Immune Responses Immunology 2 works
- 10 CRISPR and Genetic Engineering Molecular Biology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Miltenyi Biotec (Germany)'s research output changed?
Output in 2018–2022 was 20% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cologne
- University of Cologne
- Deutsches Zentrum für Luft- und Raumfahrt e. V. (DLR)
- University Hospital Cologne
- LVR-Klinik Köln
- Laboratory Dr. Wisplinghoff
- German Sport University Cologne
- Klinik und Poliklinik für Neurologie
- TH Köln - University of Applied Sciences
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.